Xvivo Perfusion AB (0RKL.LSE) Q4 2025 Earnings

23OctConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.38
0.21
0.79
1.37

Details

Expected EPS
0.43347253152419996
Actual EPS
0.254941487991
Surprise EPS
-0.18
Surprise Percent
+41.19%

Description

Xvivo Perfusion AB (0RKL.LSE) has reported earnings of 0.254941487991 per share for Q4 2025.

0 Comments

Share your thoughts